Related Experiment Video
Updated: Aug 12, 2026

15:03
Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes
Published on: July 4, 2007
Malaria parasite and vector genomes: partners in crime
Alister Craig1, Susan Kyes, Hilary Ranson
1Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK. agcraig@liv.ac.uk
Trends in Parasitology
|August 7, 2003
Summary
Genome sequencing of the malaria parasite Plasmodium falciparum and the Anopheles gambiae mosquito enables new research into drug discovery and novel therapies against malaria. This advancement allows for detailed study of parasite and vector biology.
Area of Science:
- Genomics
- Parasitology
- Vector Biology
Background:
- Malaria remains a significant global health challenge, caused by Plasmodium parasites transmitted by Anopheles mosquitoes.
- Understanding the genetic makeup of both the parasite and its vector is crucial for effective disease control.
Purpose of the Study:
- To leverage the newly available genome sequences of Plasmodium falciparum and Anopheles gambiae.
- To explore advanced research avenues for drug and insecticide discovery.
- To identify novel therapeutic strategies against malaria.
Main Methods:
- Utilizing high-throughput technologies for analyzing global transcription and translation.
- Employing computational tools for in-depth genomic analysis.
- Investigating complex biological changes in development, growth, and response to stimuli.
Main Results:
- Enabled comprehensive studies of Plasmodium falciparum and Anopheles gambiae at the genomic level.
- Facilitated research into mechanisms of drug and insecticide resistance.
- Opened pathways for the discovery of new antimalarial drugs and vector control agents.
Conclusions:
- The genome sequences provide a powerful foundation for advancing malaria research.
- New therapeutic and control strategies can be developed based on this genomic information.
- Continued research will accelerate the fight against malaria.
Related Concept Videos
Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Diversity of Protists I
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
Diversity of Protists II
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

